logo
[breadcrumb_custom]

Tag: Madrigal Pharmaceuticals Inc.

Industry

MDGL’s Market Whiplash: 14.82% YTD Rise, 13.96% Rise in 30 Days

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 14.82%. However, over the past six months, we’ve seen a weaker performance of 62.42%. The price of MDGL fallen by 13.96% over the last 30 days. And in the last five days, it has surged by 1.15%. Madrigal Pharmaceuticals Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $322.67 on 05/01/23, and the lowest

News

Navigating MDGL Stock: Madrigal Pharmaceuticals Inc Journey

The stock market performance of Madrigal Pharmaceuticals Inc has been very steady. Over the last year, the company’s stock hit its highest at $322.67 on 05/01/23, while the lowest price during the same time frame was $119.76, recorded on 10/27/23. 52-week price history of MDGL Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Madrigal Pharmaceuticals Inc’s current trading price is -19.58% away from its 52-week high, while its distance from the 52-week low is 116.68%. The stock’s price range for this

VIPS stock
Stock

Madrigal Pharmaceuticals Inc: Weathering Stock Market Storms with 4.66B Market Cap

Madrigal Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $322.67 on 05/01/23 and a low of $119.76 for the same time frame on 10/27/23. 52-week price history of MDGL Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Madrigal Pharmaceuticals Inc’s current trading price is -26.80% away from its 52-week high, while its distance from the 52-week low is 97.23%. The stock’s price range during the 52-week period has remained between $119.76 and $322.67. In